Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort

scientific article

Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.24020
P932PMC publication ID2760833
P698PubMed publication ID18759263
P5875ResearchGate publication ID23225583

P50authorRobert P. KimberlyQ41183568
Graciela S AlarcónQ67485107
John D ReveilleQ67485113
Carl D. LangefeldQ102208371
Miranda C. MarionQ112947458
Jeffrey C EdbergQ114385251
LUMINA Study GroupQ114722503
Mandar ApteQ114722505
P2093author name stringJie Zhang
Luis M Vilá
Sergio Durán
P2860cites workUpdating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.Q31143990
Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.Q33331408
Autoimmune hemolytic anemia in patients with systemic lupus erythematosusQ33331802
A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese populationQ33332503
Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.Q33342337
Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems.Q33346622
Lupus thrombocytopenia: clinical implications and prognostic significanceQ33367827
Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?Q33369397
Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosusQ33384656
Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies.Q33435725
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibodyQ33459225
The significance of thrombocytopenia in systemic lupus erythematosusQ33480020
Hemocytopenia as initial manifestation of systemic lupus erythematosus. Prognostic significance.Q33480739
Hematologic aspects of systemic lupus erythematosus. Current conceptsQ33493839
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosusQ35554492
Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over timeQ35637820
Autoimmune hemolytic anaemia in the antiphospholipid syndromeQ36560811
Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosusQ38290181
Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence techniqueQ38360359
Predictors of survival in systemic lupus erythematosusQ38468220
Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patientsQ40488181
The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".Q40541271
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibodyQ41252488
A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patientsQ42434981
Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes IndexQ43454995
Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study GroupQ43589680
Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) groupQ43654524
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurtureQ46187058
Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrualQ46223662
Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. NurtureQ46430510
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.Q50562581
Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.Q53614605
Genetic linkage and association of Fc? receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosusQ57329945
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosusQ57740770
Dimensions of illness behaviour as measured by the Illness Behaviour Questionnaire: a replication studyQ70531938
A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identificationQ72293586
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International ComparisonQ73471436
Baseline characteristics of a multiethnic lupus cohort: PROFILEQ77956670
Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrualQ79169566
Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 casesQ83313513
The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness indexQ93618721
P433issue9
P921main subjectsystemic lupus erythematosusQ1485
hemolytic anemiaQ1145668
multiethnicityQ111242702
P304page(s)1332-1340
P577publication date2008-09-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleFeatures associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort
P478volume59

Reverse relations

cites work (P2860)
Q64076051Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia
Q38059457Anaemia in inflammatory rheumatic diseases
Q33436595Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients
Q33389586Autoimmune hemolytic anemia in systemic lupus erythematosus: association with thrombocytopenia
Q57805070Changes in Hemoglobin Concentrations Post-immunoglobulin Therapy in Patients with Kawasaki Disease: A Population-Based Study Using a Claims Database in Japan
Q33431535Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study
Q34056050Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.
Q28301151Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

Search more.